Structure-activity relationships of potentiators of the antibiotic activity of clarithromycin against Escherichia coli.

[1]  Erika L. Moen,et al.  Cationic Branched Polyethylenimine (BPEI) Disables Antibiotic Resistance in Methicillin‐Resistant Staphylococcus epidermidis (MRSE) , 2018, ChemMedChem.

[2]  Morten H. H. Nørholm,et al.  Increasing the permeability of Escherichia coli using MAC13243 , 2017, Scientific Reports.

[3]  M. Pucci,et al.  Treatment of Gram-negative bacterial infections by potentiation of antibiotics. , 2016, Current opinion in microbiology.

[4]  W. Kern,et al.  Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB , 2016, Antimicrobial Agents and Chemotherapy.

[5]  T. Opperman,et al.  Recent advances toward a molecular mechanism of efflux pump inhibition , 2015, Front. Microbiol..

[6]  H. Nikaido,et al.  Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli , 2013, Antimicrobial Agents and Chemotherapy.

[7]  Marcel Tigges,et al.  Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance. , 2012, Current opinion in pharmacology.

[8]  L. L. Franco,et al.  Synthesis and Antimalarial Activity of Dihydroperoxides and Tetraoxanes Conjugated with Bis(benzyl)acetone Derivatives , 2012, Chemical biology & drug design.

[9]  M. Webber,et al.  A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli. , 2010, The Journal of antimicrobial chemotherapy.

[10]  M. Benincasa,et al.  Rapid and Reliable Detection of Antimicrobial Peptide Penetration into Gram-Negative Bacteria Based on Fluorescence Quenching , 2009, Antimicrobial Agents and Chemotherapy.

[11]  J. Pagés,et al.  Inhibitors of efflux pumps in Gram-negative bacteria. , 2005, Trends in molecular medicine.

[12]  G. Kaatz.  Bacterial efflux pump inhibition. , 2005, Current opinion in investigational drugs.

[13]  J. Pagés,et al.  The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli , 2004, Antimicrobial Agents and Chemotherapy.

[14]  T. Renau,et al.  Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. , 2002, Bioorganic & medicinal chemistry letters.

[15]  T. Renau,et al.  Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa. , 2001, Bioorganic & medicinal chemistry letters.

[16]  Angela Lee,et al.  Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy , 2001, Antimicrobial Agents and Chemotherapy.

[17]  T. Renau,et al.  Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. , 1999, Journal of medicinal chemistry.